SCOTT WELDON: Open Payments
NPI 1831287564 · SPOKANE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$546 in 23 payments from 12 companies in 2025. Trend: 2023 $21 · 2024 $1,358 · 2025 $546
Food & beverage: $546
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 1 | $100 |
| PFIZER INC. | 4 | $79 |
| ABBVIE INC. | 3 | $78 |
| Amgen Inc. | 4 | $64 |
| Novo Nordisk Inc | 3 | $50 |
| Sumitomo Pharma America, Inc. | 2 | $39 |
| Globus Medical, Inc. | 1 | $32 |
| Corcept Therapeutics | 1 | $27 |
| Exact Sciences Corporation | 1 | $23 |
| Lundbeck LLC | 1 | $20 |
Products named: REXULTI, OTEZLA, VRAYLAR, NURTEC ODT, PREVNAR 20, GEMTESA, Wegovy, Senza.
Industry payments across WA — which companies pay providers there.
